NAGE Q2 2022 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$423M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M-5.5% YoY

Gross Profit

$10M60.0% margin

Operating Income

-$6M-38.2% margin

Net Income

-$6M-38.2% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

-3.1%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$47M

Total Liabilities

$26M

Stockholders' Equity

$21M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$18M	-5.5%
Gross Profit	$10M	$11M	-7.1%
Operating Income	-$6M	-$6M	-15.0%
Net Income	-$6M	-$6M	-14.9%